What is GUTS's P/E ratio?

FRACTYL HEALTH, INC. COMMON STOCK (GUTS) currently trades at a P/E ratio of 13.59.

FRACTYL HEALTH, INC. COMMON STOCK reports a Return on Equity (ROE) of -505.22%.

What is GUTS's dividend yield?

FRACTYL HEALTH, INC. COMMON STOCK offers a dividend yield of 0.00%.

What is GUTS's Deepscope Quality Score?

Deepscope rates GUTS's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy GUTS?

Deepscope's AI Timing Score for GUTS is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does GUTS belong to?

FRACTYL HEALTH, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

GUTS (NASDAQ) Stock Analysis | FRACTYL HEALTH, INC. COMMON STOCK

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

GUTS

FRACTYL HEALTH, INC. COMMON STOCK

US:NASDAQ STOCK Healthcare >> Biotechnology News 90

USD 0.76

-0.03 (-3.76%) Day Change

Watchlist Portfolio Compare Chart

13.59

P/E

1.65

D/E

-505.2%

ROE

-108.7%

ROA

0.00%

Div Yield

0.50

PEG

FRACTYL HEALTH, INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.76 Price -0.03 (-3.76%) Day Change	NEWS SCORE: 90

GUTS, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	90
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.76
PBV / Sector	5.86 / 4.48
Earning Per Share	-0.66

PE / Sector	13.59 / 16.68
PEG or PE/Growth / Sector	0.50 / 0.53 GOOD
Average 1M Daily Value	1.93 M GREAT
Average 1W Daily Value	1.16 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

39%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 450.37
NPM Average (%) / Sector	-69,053.51 / -1,506.30
NPM Change Average (%) / Sector	N/A / 4,941.44
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-108.67 / 30.83
ROA Average (%) / Sector	-93.14 / -347.12
ROA Change Average (%) / Sector	17.96 / 5,126.35 GOOD
ROE (%) / Sector	-505.22 / -3.04
ROE Average (%) / Sector	-439.02 / 40.76
ROE Change Average (%) / Sector	-159.92 / 2,110.63
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.25

Registration Details

Analyze Date	2026-06-04 09:24:12
Symbol	GUTS
Name	FRACTYL HEALTH, INC. COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	158.65 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	125.29 / 8,483.11

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 3 Van de Graaff Drive, Burlington, MA, United States, 01803

Phone: 781 902 8800

Website: https://fractyl.com

Employees: 100

Sector: Healthcare >> Biotechnology

Description: Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.